BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+34.37%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$893M
AUM Growth
+$893M
(+17%)
Cap. Flow
-$99.6M
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
59
New
4
Increased
15
Reduced
14
Closed
6
Top Buys
| 1 |
AC Immune
ACIU
|
$26.4M |
| 2 |
Mersana Therapeutics
MRSN
|
$13.2M |
| 3 |
CytomX Therapeutics
CTMX
|
$12.9M |
| 4 |
Replimune Group
REPL
|
$10.8M |
| 5 |
Voyager Therapeutics
VYGR
|
$5.94M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$72.5M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$32.3M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$18.8M |
| 4 |
Xencor
XNCR
|
$18.4M |
| 5 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$11.4M |
Sector Composition
| 1 | Healthcare | 90.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
| $1.07M | 0.12% |
105,194
| – | – |
|
|
CFRX
52
DELISTED
ContraFect Corporation
CFRX
| $755K | 0.08% |
2,374
| – | – |
|
|
53
Xencor
XNCR
$594M
| $28K | ﹤0.01% |
904
-592,561
| -100% | -$18.4M |
|
54
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-9,399
| Closed | -$508K |
|
55
KalVista Pharmaceuticals
KALV
$713M
| – | – |
-252,693
| Closed | -$4.99M |
|
|
PRNB
56
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| – | – |
-146,300
| Closed | -$4.01M |
|
|
LOXO
57
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-3,944
| Closed | -$552K |
|
|
MACK
58
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-917,579
| Closed | -$2.79M |
|
|
IMDZ
59
DELISTED
Immune Design Corp.
IMDZ
| – | – |
-5,185,383
| Closed | -$6.74M |
|